JPRN-jRCT1080224120已完成Unknown
AZILECT Tablets Special Drug Use-Results Survey Survey on Long-term Safety
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 1,021 人开始时间: 2018年10月30日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 1,021
研究概览
简要总结
o new concerns regarding the long-term safety or efficacy of this drug in participants with Parkinson's disease.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with Parkinson's disease should be surveyed.
排除标准
- •- Participants who have contraindications on package insert of rasagiline.
研究者
相似试验
已完成
不适用
Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"Parkinson's DiseaseNCT03727139Takeda1,021
已完成
Unknown
Specified Drug-Use Survey of Trelagliptin Tablets Survey on long-term use in patients with type 2 diabetes mellitusType 2 Diabetes MellitusJPRN-jRCT1080223923Takeda Pharmaceutical Company Limited3,198
已完成
不适用
Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"Type 2 Diabetes MellitusNCT02003014Takeda899
已完成
不适用
Azilsartan Tablets Special Drug Use Surveillance: Long-term UseHypertensionNCT02092025Takeda3,437
已完成
不适用
The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes PatientsType 2 DiabetesNCT02297620Astellas Pharma Inc8,687